Natco Pharma Ltd

NSE: NATCOPHARM · BSE: 524816 · Pharmaceuticals & Biotechnology · 36 announcements

Share price: ₹823.65
Market cap: ₹16,157 Cr
Revenue (annual): ₹4,078 Cr
Net profit (annual): ₹1,418 Cr
P/E (TTM): 14.1×Sector 47.4×
Promoter holding: 49.42%+0.00% QoQ
FII holding: 16.99%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

14 Jul 2026 11:49 IST BSE

Natco Pharma Merger & Restructuring Worth ₹1,060 Cr

Natco Pharma completed the acquisition of an additional 13.25% stake in Adcock Ingram for ₹1,060 Crore. This transaction increases Natco's total shareholding to 49%.

Value: ₹1,060 Cr

Read the filing ↗